JCOG1805 (PanDRa-BD study): A randomized controlled study of adjuvant chemotherapy for stage II colorectal cancer patients at high-risk of developing recurrence according to T-stage and three selected pathological factors (Pn, DR, and BD).

Authors

Megumi Ishiguro

Department of Chemotherapy and Oncosurgery, Tokyo Medical and Dental University, Tokyo, Japan

Megumi Ishiguro , Hideki Ueno , Atsuo Takashima , Junki Mizusawa , Keita Sasaki , Hiroshi Katayama , Tetsuya Hamaguchi , Shunsuke Tsukamoto , Yukihide Kanemitsu

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Sign-In

Similar Posters

insert_chart_outlined

Poster

2022 ASCO Annual Meeting

bookmark_border

Cost-effectiveness of adjuvant chemotherapy for patients with high-risk stage II and stage III colon cancer in South Africa.

First Author: Yoanna S Pumpalova

insert_chart_outlined

Poster

2020 ASCO Virtual Scientific Program

bookmark_border

TRACC: Tracking mutations in cell-free DNA to predict relapse in early colorectal cancer—A randomized study of circulating tumour DNA (ctDNA) guided adjuvant chemotherapy versus standard of care chemotherapy after curative surgery in patients with high risk stage II or stage III colorectal cancer (CRC).

First Author: Gayathri Anandappa

insert_chart_outlined

Poster

2018 Gastrointestinal Cancers Symposium

bookmark_border

Clinical impact of diverting ileostomy on the dose intensity of adjuvant chemotherapy for colorectal cancer.

First Author: Shusuke Yagi

insert_chart_outlined

Poster

2017 ASCO Annual Meeting

bookmark_border

Association between timing and duration of adjuvant chemotherapy and survival for colorectal cancer in korea, 2011-2014: A nationwide study based on the database of quality assessment and the health insurance.

First Author: In Gyu Hwang